C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/16 (2006.01) A01K 67/027 (2006.01) A61K 31/7088 (2006.01) A61K 31/7105 (2006.01) A61K 31/713 (2006.01) A61K 48/00 (2006.01) C07H 21/00 (2006.01) C07K 14/72 (2006.01) C07K 16/28 (2006.01) C12N 15/12 (2006.01) C12P 19/34 (2006.01) C12Q 1/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/563 (2006.01) G01N 33/566 (2006.01) G01N 33/58 (2006.01)
Patent
CA 2649770
This invention is directed to mutated Activin A type I receptor proteins (ACVR1) and isolated nucleic acids encoding same. The invention also relates to the use of mutated ACVR1 in the diagnosis and treatment of Fibrodysplasia Ossificans Progressiva (FOP).
L'invention concerne des protéines mutantes du récepteur de l'activine A de type I (ACVR1) et des acides nucléiques isolés codant pour ce récepteur. L'invention se rapporte également à l'utilisation de ces ACVR1 mutants pour le diagnostic et le traitement de la fibrodysplasie ossifiante progressive (FOP).
Kaplan Frederick S.
Shore Eileen M.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
The Trustees Of The University Of Pennsylvania
LandOfFree
Mutated acvr1 for diagnosis and treatment of fibrodyplasia... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutated acvr1 for diagnosis and treatment of fibrodyplasia..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutated acvr1 for diagnosis and treatment of fibrodyplasia... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1469856